«Factor Viia

Below is an extended Factor Viia patents listing. Click here to return to the Factor Viia main in depth entry.

Patents :
US Patent No.	Title
7390883	PRO4428 antibodies
7408032	PRO1188 polypeptides
7408033	PRO5995 polypeptides
7408042	Anti-PRO6181 antibodies
7411040	PRO6182 polypeptides
7411047	PRO6097 antibodies
7412332	Method for analyzing polysaccharides
7414022	Factor VII or VIIa-like molecules
7416858	Pharmaceutical compositions of glycoconjugates
7416860	Nucleic acids encoding human coagulation factor VII variants
7416861	Human coagulation factor VII polypeptides
7407974	Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
7407972	Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
7407475	Modified annexin proteins, and methods and compositions for using them
7390887	Antibodies against PRO4330
7390908	Compounds effecting glucokinase
7392140	Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
7393833	Chimeric proteins with phosphatidylserine binding domains
7396906	Pro4399 Polypeptides
7396907	Antibodies that bind PRO6182 polypeptides
7396916	Antibody to a polypeptide overexpressed in tumors
7399613	Sialic acid nucleotide sugars
7399743	Targeted thrombosis
7404956	Immunoglobulin chimeric monomer-dimer hybrids
7417024	Template-fixed peptidomimetics as inhibitors of serine proteases
7417039	Use of substituted azetidinone compounds for the treatment of sitosterolemia
7425641	Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
7427490	Diagnostic markers of stroke and cerebral injury and methods of use thereof
7427592	Factor VII or VIIa - like molecules
7427618	Ethynyl derivatives as factor Xa inhibitors
7427659	Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction
7429566	Method for treating Hemophilia B
7429581	Pyrazole-derivatives as factor Xa inhibitors
7429597	Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions
7429604	Six-membered heterocycles useful as serine protease inhibitors
7429611	Indole inhibitors of 15-lipoxygenase
7425621	Antibodies against the PRO4401 polypeptide
7425609	PRO4330 polypeptides
7425539	Factor IXa for the treatment of bleeding disorders
7417063	Bicyclic heterocycles useful as serine protease inhibitors
7417115	PRO6027 polypeptides
7417123	PRO4399 Antibodies
7419803	Nucleic acids encoding human coagulation Factor VII polypeptides
7419948	Treatment of hemophilia with human Factor IX produced in mammary tissue of transgenic mammals
7419949	Single-dose administration of factor VIIa
7422738	Combined cancer treatment methods using antibodies to aminophospholipids
7423009	Method for treatment of kidney diseases
7423017	Method for treating cartilage disorders
7425328	Tissue factor antibodies and uses thereof
7429640	PRO6181 polypeptides

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.